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Abstract
Objectives: The aim of the present study was to compare a newly developed biodegradable
polylactide/polyglycolide/N-methyl-2-pyrrolidone (PLGA/NMP) membrane with a standard resorbable
collagen membrane (RCM) in combination with and without the use of a bone substitute material
(deproteinized bovine bone mineral [DBBM]) looking at the proposed tenting effect and bone
regeneration. Materials and methods: In five adult German sheepdogs, the mandibular premolars P2, P3,
P4, and the molar M1 were bilaterally extracted creating two bony defects on each site. A total of 20
dental implants were inserted and allocated to four different treatment modalities within each dog:
PLGA/NMP membrane only (Test 1), PLGA/NMP membrane with DBBM (Test 2), RCM only
(negative control), and RCM with DBBM (positive control). A histomorphometric analysis was
performed 12 weeks after implantation. For statistical analysis, a Friedman test and subsequently a
Wilcoxon signed ranks test were applied. Results: In four out of five PLGA/NMP membrane-treated
defects, the membranes had broken into pieces without the support of DBBM. This led to a worse
outcome than in the RCM group. In combination with DBBM, both membranes revealed similar
amounts of area of bone regeneration and bone-to-implant contact without significant differences. On
the level of the third implant thread, the PLGA/NMP membrane induced more horizontal bone
formation beyond the graft than the RCM. Conclusion: The newly developed PLGA/NMP membrane
performs equally well as the RCM when applied in combination with DBBM. Without bone substitute
material, the PLGA/NMP membrane performed worse than the RCM in challenging defects, and
therefore, a combination with a bone substitute material is recommended. To cite this article: Jung RE,
Kokovic V, Jurisic M, Yaman D, Subramani K, Weber FE. Guided bone regeneration with a synthetic
biodegradable membrane: a comparative study in dogs. Clin. Oral Impl. Res. xx, 2010; 000-000.
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Abstract  
Objectives: The aim of the present study was to compare a newly developed  
biodegradable polylactide/polyglycolide/N-methyl-2-pyrrolidone (PLGA/NMP) 
membrane with a standard resorbable collagen membrane (RCM) in combination 
with and without the use of a bone substitute material (DBBM) looking at proposed 
tenting effect and bone regeneration. Materials and Methods: In five adult German 
sheepdogs the mandibular premolars P2, P3, P4 and the molar M1 were bilaterally 
extracted creating two bony defects on each site. A total of 20 dental implants were 
inserted and allocated to four different treatment modalities within each dog: 
PLGA/NMP membrane only (Test 1), PLGA/NMP membrane with DBBM (Test 2), 
resorbable collagen membrane (RCM) only (negative control), and RCM with DBBM 
(positive control). A histomorphometric analysis was performed 12 weeks after 
implantation. For statistical analysis a Friedman test and subsequently a Wilcoxon 
signed ranks were applied. Results: In 4 out of 5 PLGA/NMP membrane-treated 
defects, the membranes had broken into pieces without the support of DBBM. This 
led to a worse outcome than in the RCM group. In combination with DBBM both 
membranes revealed similar amounts of area of bone regeneration and bone-to-
implant contact without significant differences. On the level of the 3rd implant thread, 
the PLGA/NMP membrane induced more horizontal bone formation beyond the graft 
than the RCM. Conclusion: The newly developed PLGA/NMP membrane performs 
equally well as the RCM when applied in combination with DBBM. Without bone 
substitute material the PLGA/NMP membrane performed worse than the resorbable 
collagen membrane in challenging defects, and therefore, a combination with a bone 
substitute material is recommended.  
 
 
Introduction 
In the field of Guided Bone Regeneration (GBR), there has been a dramatic reduction 
in the use of non-resorbable membrane like the expanded polytetrafluoroethylene 
(ePTFE), due to difficulties in handling, the need for a second surgery to remove the 
membrane, and the low reproducibility of results when membrane exposure had 
occurred resulting in wound infection and subsequently poor bone regeneration 
(Gher et al. 1994; Machtei 2001; Simion et al. 1994). To overcome these 
shortcomings, non-resorbable membranes were replaced in many indications by 
resorbable collagen membranes made from bovine or porcine sources (Hammerle & 
Lang 2001; Parodi et al. 1998). With improved biocompatibility, biodegradability, and 
better treatment results most clinicians nowadays use resorbable collagen 
membranes (Hammerle et al. 2008; Lang et al. 2007).. All collagen membranes 
originate from animal sources, which can cause difficulties for patient acceptance, 
immune responses, and a transmission of infectious agents can never be completely 
excluded. Few studies have reported that these membranes do exhibit unfavourable 
mechanical properties (Hurzeler et al. 1998) and inadequate barrier stability over time 
(Miller et al. 1996; Owens & Yukna 2001; Zhao et al. 2000).  
The usage of synthetic resorbable membranes made from aliphatic polyesters like 
polylactide, polyglycolide and trimethylcarbonate have also been reported (Kohal & 
Hurzeler 2002; Rosen & Reynolds 2001). However, the degradation process of 
synthetic membranes made of polylactide or polyglycolide acids can impair bone 
regeneration due to adverse inflammatory tissue reaction (von Arx et al. 2005; von 
Arx et al. 2002). Therefore, the development of a membrane based on biocompatible 
synthetic material with a long record of accomplishment in human use would 
represent an important step forward in guided bone regeneration and in implantology. 
In this trial, a biodegradable fully synthetic membrane composed of polylactide, 
polyglycolide and trimethylene carbonate (PLGA) membrane was employed as a 
barrier membrane for guided bone regeneration in the dog mandible. The PLGA 
based membrane is degradable by hydrolysis and releases N-methyl-2-pyrrolidone 
(NMP), which was shown to accelerate maturation of pre-osteoblastic cells and bone 
regeneration in vitro and in vivo in a cranial defect model in rabbits (Miguel et al. 
2009). Hence, it might be expected that this PLGA/NMP membrane is capable of 
enhancing bone regeneration in a guided bone regeneration (GBR) model in humans 
as well. Unlike collagen based membranes, PLGA-based membranes are stiff and 
can only be used clinically for GBR when softened by a plasticizer, such as NMP. 
Since NMP is released from the membrane when in contact with body fluids 
(Pirhonen et al. 2006), the applied membrane gets stiff again which might allow to 
omit the use of membrane supporting materials. Due to the low mechanical stability 
collagen derived membranes are mainly applied in combination with bone substitute 
materials (Cornelini et al. 2004; Jung et al. 2003). 
The aim of this study was to compare the PLGA/NMP membrane to a standard 
resorbable collagen membrane with and without the addition of deproteinized bovine 
bone mineral (DBBM) as bone substitute material and to determine their potential 
applications in GBR.  
 
Materials and Methods  
Materials 
The collagen membrane Bio-Gide®  and the bone substitute material Bio-Oss®  were 
purchased from Geistlich AG, Wolhusen, Switzerland. The synthetic Inion® GTRTM 
membrane and the resorbable pins were purchased from Inion Oy, Tampere, 
Finland. The Straumann Dental Implant System was purchased from Straumann AG, 
Basel, Switzerland. Both membranes were applied as recommended by the 
manufacturer. The following procedures was used for the novel PLGA/NMP 
membrane: After unwrapping, the stiff PLGA membrane was located in a tray. To 
soften the PLGA membrane the supplied N-methyl-2-pyrrolidone (NMP) solution was 
added to the tray and allowed to penetrate the membrane for 30 seconds. After 
soaking, the membrane was taken from the tray with tweezers and placed for 10 
minutes in the second part of the tray to allow an even distribution of NMP 
throughout the membrane and an air drying of its surface. Then the originally stiff 
membrane had turned into a soft membrane which can be applied clinically.  
 
Animals 
Five adult German sheepdogs, weighing more than 20 kg, were used in the present 
study. The animals were kept in purpose-designed room for experimental animals 
and were fed with a standard laboratory diet. The study was evaluated and accepted 
by the responsible Veterinary Authority (University of Belgrade, Serbia). All surgical 
procedures including extraction and implant placement were performed under 
general anaesthesia according to an earlier study (Jung et al. 2007). 
 
Surgical procedure 
Oral prophylaxis comprising of calculus removal and chlorhexidine swabs was 
performed one week prior to tooth extraction and one week prior to the regenerative 
surgery using drug sedation.  
Surgery 1 (tooth extraction) 
From 5 dogs, the mandibular premolars P2, P3, P4 and the molar M1 were extracted 
bilaterally. Wound closure was achieved using resorbable sutures.  
 
Surgery 2 (implantation and lateral ridge augmentation) 
Implantation and regenerative surgery was performed three months following tooth 
extraction. Following mid-crestal incisions of 2.5 cm in length as well as buccal 
vertical releasing incisions distal to the canine, a full thickness flap was carefully 
elevated. On each side of the mandible two angular ridge form defects with the 
following dimensions were created: 9 mm in mesio-distal direction, 5 mm in apical-
coronal direction, and 7 mm in bucco-oral direction. A total of 20 experimental 
implants with a sandblasted, large-grit, acid-etched (SLA) surface up to the shoulder 
of the Straumann Dental Implant System (Straumann AG, Basel, Switzerland) with a 
diameter of 3.3 mm and a length of 8 mm were placed obtaining primary stability 
(Fig. 1a, b).  
One implant was placed per defect in such a way that the implant-shoulder was 
vertically located at the level of the alveolar bone crest at the lingual side. This 
resulted in a buccal dehiscence defect (Fig. 1b).  At this time point the vertical defect 
extension was measured from the top of the implant cylinder shoulder to the first 
bone to implant contact at the buccal aspect. 
The four implants inserted in each of the five dogs were randomly allocated to the 
PLGA/NMP group or RCM group either in combination with DBBM or without 
resulting in the following four treatment modalities:  
Test 1 - PLGA/NMP mebrane only    
biodegradable polylactide, polyglycolide, trimethylene carbonate based and N-
methylpyrrolidone (NMP) releasing membrane (PLGA/NMP) membrane (Inion® 
GTRTM) without bone substitute material. 
Test 2 – PLGA/NMP membrane with DBBM   
biodegradable PLGA/NMP membrane (Inion® GTRTM) with deproteinized bovine 
bone mineral (DBBM) (Bio-Oss®) as bone substitute material. 
Positive control – RCM with DBBM  
Resorbable collagen membrane (RCM) (Bio-Gide®) with deproteinized bovine bone 
mineral (DBBM) Bio-Oss® as bone substitute material.  
Negative control – RCM only   
Resorbable collagen membrane (RCM) (Bio-Gide®) without bone substitute material. 
 
For the Test 2 and positive control modalities the DBBM granules were mixed with a 
sterile saline solution and placed into the bone defects. Before applying the 
membrane, the horizontal defect extensions were measured from the buccal implant 
surface to the most buccal aspect of the graft material. Both types of membranes 
were trimmed and draped over the defect and the adjacent ridge in order to overlap 
the defect margins 2 to 3 mm. Each membrane was secured at the buccal aspect 
with two resorbable trimethylene carbonate/ D, L-lactide tacks (Inion OY, Tampere, 
Finland.) and tucked underneath the lingual flap (Fig. 2a,b). At the test sites, the 
bioresorbable PLGA/NMP membranes were moistened with sterile saline solution 
and subsequently the membrane became stiff after approximately 90 seconds.  
To allow a tension-free wound closure, the periosteum of the buccal flap was relieved 
along the entire base. Thereafter, primary wound closure was obtained with vertical 
mattress and interrupted e-PTFE sutures (Gore-Tex® sutures 5.0, W.L. Gore & 
Assoc., Flagstaff, USA). At the end of each surgical procedure and twice thereafter, 
analgesic (Baralgin®) was intramuscularly injected to reduce postoperative pain. The 
dogs remained on a soft diet for the remainder of the study. The dogs were kept in a 
purpose-designed cage and allowed once a day 2 hours into an outdoor 
environment. The sutures were removed 10 days after surgery.  
Three months following regenerative surgery, animals were sacrificed with an 
overdose of intravenous sodium pentobarbital under deep anesthesia. All sites were 
harvested with intact soft tissues. 
 Histological preparation 
Fixation of the block sections were performed in 4% formaldehyde for 2 weeks. 
Following fixation, the specimens were rinsed in running tap water, trimmed and 
dehydrated in a graded series of increasing ethanol concentrations. Embedding was 
done in methylmethacrylate. Tissue blocks were cut into 200 µm-thick vertical 
sections using a diamond saw (Exakt, Germany). The sections were ground and 
polished to a final thickness of 40-80 µm (Exakt, Germany), and surface-stained with 
toluidine blue (Schenk, et al. 1984). 
 
Histomorphometry 
From each specimen the central orofacial section through the implant was selected 
for quantitative assessment of different linear measurements (vertical and horizontal 
extension of the regenerated bone), interfaces, and various tissue components by 
applying standard morphometrical techniques (Gundersen et al. 1988; Weibel, et al. 
1966). Measurements were done directly under a light microscope (Leica 
Microsystems AG, Heerbrugg, Switzerland). 
Linear measurements were performed at a magnification of 40 times in order to 
calculate the amount of regenerated bone in the former defect area:  
a) The area of regenerated bone was calculated as the area of newly formed 
bone in mm2 within the area outlined by the membrane. 
b) Bone-to-implant contact was evaluated from the base of the prepared defect 
to the implant shoulder and was calculated in mm. 
c) The vertical extension of the regenerated bone was measured from the 
implant shoulder to (i) the highest bone to implant contact and (ii) to the 
highest extension of newly formed bone at the buccal side of the implant. The 
implant shoulder was set as zero and negative values represent bone tissue 
below the implant shoulder, whereas positive values reveal bone tissue above 
the implant shoulder. 
d) To obtain quantitative information about the horizontal extension of 
regenerated bone, the distance from the outer surface of the regenerated 
bone to the implant surface was measured perpendicular to the implant at the 
level of the first 3 threads.  
e) To obtain quantitative information about the horizontal extension of 
regenerated bone beyond the augmented area, the distance form the outer 
surface of the regenerated bone to the outer surface of the graft material was 
measured perpendicular to the implant at the level of the first 3 threads. 
Negative values represent graft material exceeding bone tissue horizontally, 
whereas positive values reveal bone tissue formation beyond the graft 
material. 
 
Statistical analysis 
All data for statistical variables of new bone formation, membrane material, and non-
mineralized tissue were first analyzed by a Friedman test and if applicable by a 
Wilcoxon signed ranks test using the SSPS software Version 18.0 (SPSS Inc. 
Chicago, USA). The animal was chosen as the unit for statistical analysis. The level 
of significance chosen in all statistical tests was set at P <0.05. 
 
Results 
All surgical procedures went uneventful with the exception of one dog, where 
residual tooth pieces were found. Since the removal of these pieces led to a very 
huge defect, no implant could be placed at one of the 4 defect sites. This situation 
led to the exclusion of this site from further analysis. Before and after the surgical 
procedures all dogs stayed in good health. Soft tissue healing was excellent at all 
sites and no dehiscence was detected. Histological analysis (Fig. 3d) revealed that in 
4 out of 5 PLGA/NMP membrane-treated defects the membranes had broken into 
pieces. In the PLGA/NMP membrane/DBBM group only 1 membrane had broken 
(Fig. 3b). Therefore, the tenting effect of the PLGA/NMP membrane is apparently not 
sufficient to maintain the space in extended defects in dogs. However, when 
supported by bone substitute material (DBBM) the stability increased substantially. In 
terms of bone formation the fracture of the one PLGA/NMP membrane in the 
PLGA/NMP membrane/DBBM group had no negative impact on bone formation. In 
contrast to the PLGA/NMP membrane, all resorbable collagen membranes remained 
intact at all sites and presumably, maintained their barrier function (Fig. 3a,c). 
The histomorphometric data are displayed in Table 1. As shown in Fig. 4a, the area 
of regenerated bone was identical for both membranes in the DBBM group and in the 
group without DBBM. In addition, the influence of the membrane on the bone/implant 
interphase was evaluated. As shown in Fig. 4b, the two membranes had no 
significant influence on the bone-to-implant contact. But without bone substitute 
material the overall bone-to-implant contact was higher in the resorbable collagen 
membrane group compared to the PLGA/NMP group. Significant was the difference 
between the PLGA/NMP group with DBBM and without DBBM. 
The success of an implant depends on its osseous integration. Therefore, highest 
point of bone-to-implant contact and highest bone tissue level were determined (Fig. 
5a,b). The results showed that between the corresponding groups (with and without 
DBBM) no significant difference could be detected. Significant was the difference 
between the highest bone tissue level of the PLGA/NMP group with DBBM compared 
to both membranes without DBBM (N=5, P=0.034) 
Horizontal bone gain was assessed at three different levels (first, second and third 
thread). The results revealed no significant difference in horizontal bone formation 
between the two membranes at any level (Fig. 6a). In addition, we determined bone 
regeneration beyond the graft material. When compared to resorbable collagen 
membranes the PLGA/NMP membrane was capable of inducing bone regeneration 
horizontally beyond the graft material in the lower region of the defect (Fig. 6b). At 
the level of the third thread there was a bigger difference between the two 
membranes, however, reaching no statistically significant difference.  
 
Discussion 
The present dog study demonstrates that a newly developed PLGA/NMP membrane 
in combination with a membrane supporting material (DBBM) revealed no significant 
differences in the majority of the tested parameters compared to the use of a 
resorbable collagen membrane (RCM) with DBBM. The only small difference of the 
PLGA/NMP membrane was that on the level of the 3rd thread of the implant, more 
bone had formed horizontally beyond the graft material in the PLGA/NMP group 
compared to the RCM group. This small edge might derive from the use of NMP, 
known to enhance autologous and recombinant bone morphogenetic proteins 
yielding into enhanced bone regeneration (Miguel et al. 2009).    
The newly developed PLGA/NMP membrane is initially composed of a stiff material 
(polyglycolide, polylactide). For medical use the material has to be softened which is 
facilitated by incubation in and influx of NMP. Upon placement in the patient and 
resulting exposure to body fluids the softener NMP is released, increasing the 
stiffness of the membrane again (Pirhonen et al. 2006). The outcome of the present 
experiment revealed that the regained stiffness is not sufficient to maintain a space 
for bone ingrowth by its own, since in 4 of 5 cases the PLGA/NMP membrane broke. 
Therefore, the tenting effect of this membrane on its own is limited. A reason for this 
outcome might be that the design of the study aimed towards a challenging defect 
size, which would not be treated without bone substitute material in a human 
situation. Since the forces applied on the membranes by the dogs could not be 
controlled beyond the feeding of soft meals, it remains unclear whether a PLGA/NMP 
membrane can withstand the ‘normal’ forces in humans. In a recent human trial the 
same membrane was used to cover extraction sockets of impacted wisdom teeth 
(Zwahlen et al. 2009). Histological data and clinical outcome provided no indications 
for membrane fractures and/or failures. However, one has to take into account that in 
this human trial the blood clot underneath the membrane had been stabilized by a 
collagen sponge and that the defects created were 4 wall instead of 3 wall bony 
defects as in the present dog model.  
It is worth mentioning that the failure of the PLGA/NMP membrane led to a worse 
outcome than the collapsing collagen membrane. This might have two reasons: First, 
the collagen membrane did not rupture and maintained its barrier function. Therefore, 
soft tissue in-growth was still prevented in the resorbable collagen membrane group, 
whereas the broken PLGA/NMP membrane allowed fibrous tissue in-growth into the 
regenerating area (Fig. 3d). Second, the pieces of the broken PLGA/NMP membrane 
stacked onto the defect and hindered new bone formation physically, leading to a 
significant reduction of the bone-to-implant contact (Fig. 4b). When the PLGA/NMP 
membrane was applied without DBBM compared to its application with DBBM, no 
significant difference was found between both membranes either applied with or 
without DBBM.  
 
An earlier study in mongrel dogs (Kohal et al. 1999) evaluated the effect of guided 
bone regeneration without application of a bone substitute material around non-
submerged implants using different barrier membranes in 3 groups: a) an expanded 
polytetrafluoroethylene membrane, b) a bioresorbable membrane made from a 
synthetic copolymer of glycolide and lactide, and c) no membrane application. The 
defects (5mm apicocoronal x 5 mm mesiodistal) were not filled with a bone substitute 
material. After a healing period of 6 months, the mineralized bone-to-implant contact 
in the bioinert e-PTFE membrane group was 51.5%, in the control group 46.3%, and 
37.5% in the biodegradable membrane group. The results of this study indicated that 
guided bone regeneration with a bioinert e-PTFE membrane was equal without using 
bone substitute material. However, compared to the present study the defect size 
was much smaller and less challenging, since all 4 bony walls were preserved.  
In combination with the bone substitute material DBBM, resorbable collagen 
membranes and PLGA/NMP membranes performed equally well in terms of area of 
bone regeneration, bone-to-implant contact, horizontal bone gain, and all the other 
parameters tested. One difference was seen in the horizontal extension of bone 
tissue compared to graft material at the level of the third thread (Fig. 6b). This result 
might be explained by the fact that NMP released from the membrane increases 
bone formation more at the bottom of a defect and closer to the membrane. The first 
vector (closer to the bottom) is most likely due to the higher density of NMP 
compared to body fluid. The second (closer to the membrane) can be due to the 
constant release of residual NMP from the membrane. Both support the concept of 
the bioactivity of NMP (Miguel et al. 2009) but also highlight the difficulty in applying it 
in traditional applications of membranes in humans, since most of the NMP will flow 
out of the defect site. This in vivo model was able to document the bioactivity of NMP 
in a calvarial defect model where PLGA/NMP membranes were placed at both sides 
of the defect. This defect anatomy allowed to trap the released NMP within the bony 
borders of the bone defect (Miguel et al. 2009). This configuration, in contrast to 
normal dental applications, might have increased the effective concentration of NMP 
in the defect and prolonged its exposure to the resident cells close to the defect 
margins with regenerative potential.  
A similar situation in humans concerning the bony walls exists in extraction sockets. 
Hence, the first clinical trial to evaluate the osteopromotive effect of NMP within the 
PLGA/NMP membrane was performed in an extraction socket model. The results of 
that clinical trial with the PLGA/NMP membrane showed that old bone density around 
the defect had increased in the PLGA/NMP group compared to the RCM group 
(Zwahlen et al. 2009), however, the number of patients and the magnitude of this 
effect was too low to show a highly significant increase in bone formation or bone 
density between the groups.  
The present study design did not include an empty control in order to assess the 
amount of spontaneous healing within this type of defects. This would allow to better 
interpret the outcome of bone regeneration, however, in the other hand the tenting 
effect of the different membranes could not been assessed. 
In conclusion, the newly developed fully synthetic biodegradable PLGA/NMP 
membrane performs equally well as the resorbable collagen based membrane when 
applied in combination with a bone substitute material. A small increase in the 
horizontal bone gain beyond the graft material at the level of the 3rd thread of the 
implant might be attributed to the osteopromotive action of NMP. Without bone 
substitute material the PLGA/NMP membrane performed worse than the resorbable 
collagen based membrane in challenging defects. Therefore, the combination with a 
bone substitute material is highly recommended. 
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Figure and table legends: 
 
Fig. 1. (a,b) Clinical photographs of bony defects prior to membrane and bone 
substitute application. The dimensions of the defects were 9 mm in mesio-distal 
direction and 5 mm in apical-coronal direction. 
Fig. 2. (a) Clinical photographs of deproteinized bovine bone mineral placed in the 
bony defects and (b) covered with PLGA/NMP membrane held in place by 
resorbable Trimethylene Carbonate/ D, L-lactide tacks. 
Fig. 3. Histological views of all treatment modalities in a single dog. (a) Resorbable 
collagen membrane (RCM) with DBBM showing good bone regeneration and (c) 
without bone substitute material. (b) The PLGA/NMP membrane group with bone 
substitute material (DBBM) shows good bone regeneration even with broken 
membrane fragments and (d) PLGA/NMP membrane group without bone substitute 
material showing the remnants of the broken PLGA/NMP membrane.  
Fig. 4. Analysis of histomorphometry. (a) Area of bone regeneration and (b) bone to 
implant contact. The lines to the right of the values indicate the median of the group. 
Significant differences between groups are indicated with (*). 
Fig. 5. (a) Distance between implant shoulder and highest bone to implant contact 
and (b) distance between implant shoulder and highest extent of bone tissue. The 
lines to the right of the values indicate the median of the group. Significant 
differences between groups are indicated with (*). 
Fig. 6. (a) Horizontal bone gain measured perpendicular to the implant at the level of 
thread 1, 2, and 3. (b) Horizontal bone gain beyond the graft material determined by 
the distance from the outer surface of the regenerated bone to the outer surface of 
the graft material measured perpendicular to the implant at the level of thread 1, 2, 
and 3. Positive values indicate that bone had formed horizontally beyond the graft 
material at the buccal side. No significant differences were observed between the 
corresponding groups. 
 
Table 1. Descriptive measurements of the histomorphometric analysis. 
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Fig. 6. (a) Horizontal bone formation measured perpendicular to the implant at the 
level of thread 1, 2, and 3. (b) Horizontal bone gain beyond the graft material 
determined by the distance from the outer surface of the regenerated bone to the 
outer surface of the graft material measured perpendicular to the implant at the level 
of thread 1, 2, and 3. Positive values indicate that bone had formed horizontally 
beyond the graft material at the buccal side. No significant differences were observed 
between the corresponding groups. 
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